These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study. Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013 [TBL] [Abstract][Full Text] [Related]
47. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET. Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031 [TBL] [Abstract][Full Text] [Related]
48. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain. Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220 [TBL] [Abstract][Full Text] [Related]
49. Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study. Marner L; Frokjaer VG; Kalbitzer J; Lehel S; Madsen K; Baaré WF; Knudsen GM; Hasselbalch SG Neurobiol Aging; 2012 Mar; 33(3):479-87. PubMed ID: 20510480 [TBL] [Abstract][Full Text] [Related]
50. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. Costes N; Merlet I; Zimmer L; Lavenne F; Cinotti L; Delforge J; Luxen A; Pujol JF; Le Bars D J Cereb Blood Flow Metab; 2002 Jun; 22(6):753-65. PubMed ID: 12045674 [TBL] [Abstract][Full Text] [Related]
51. Laterality and 5HT2 receptors in human brain. Yates M; Morris C; Cheng AV; Ferrier N Psychiatry Res; 1991 Feb; 36(2):169-74. PubMed ID: 2017531 [TBL] [Abstract][Full Text] [Related]
54. Serotonin 5-HT3 receptor binding kinetics in the cortex of suicide victims are normal. Mann JJ; Arango V; Henteleff RA; Lagattuta TF; Wong DT J Neural Transm (Vienna); 1996; 103(1-2):165-71. PubMed ID: 9026370 [TBL] [Abstract][Full Text] [Related]
55. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD. Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U Synapse; 1987; 1(5):393-8. PubMed ID: 2905532 [TBL] [Abstract][Full Text] [Related]
56. Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone. Blin J; Baron JC; Dubois B; Crouzel C; Fiorelli M; Attar-Lévy D; Pillon B; Fournier D; Vidailhet M; Agid Y Brain; 1993 Jun; 116 ( Pt 3)():497-510. PubMed ID: 8513389 [TBL] [Abstract][Full Text] [Related]
57. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis. Petit-Taboué MC; Landeau B; Osmont A; Tillet I; Barré L; Baron JC J Nucl Med; 1996 Jan; 37(1):95-104. PubMed ID: 8544011 [TBL] [Abstract][Full Text] [Related]
58. [In vivo study of central serotoninergic receptors in man using positron tomography]. Baron JC; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y Rev Neurol (Paris); 1985; 141(8-9):537-45. PubMed ID: 2935920 [TBL] [Abstract][Full Text] [Related]
59. Reduction in serotonin 5HT2 receptor binding on platelets of delinquent adolescents. Blumensohn R; Ratzoni G; Weizman A; Israeli M; Greuner N; Apter A; Tyano S; Biegon A Psychopharmacology (Berl); 1995 Apr; 118(3):354-6. PubMed ID: 7617829 [TBL] [Abstract][Full Text] [Related]